A vs CABA · P/E 29, rev $1.88B vs $143.9M cap
Agilent Technologies Inc (A) versus Cabaletta Bio Inc (CABA) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
CABA does not have a complete income-statement cache yet.
A currently screens at market cap $33.70B and trailing P/E 29.2. CABA currently screens at market cap $143.9M.
Not investment advice. Open the A and CABA stock pages for the full models.
Not investment advice.